MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-09-0008690
Finesse Pharmaceuticals Private Limited - pharma in Kalol, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹14.48 Cr
▲ 0.15% YoY
Net profit · FY 2024
₹44.75 Lakh
Net margin 3.1%
EBITDA · FY 2024
₹1.86 Cr
EBITDA margin 12.9%
Authorised capital
₹55 Lakh
Registered with MCA
Paid-up capital
₹40.91 Lakh
Issued & subscribed
Open charges
₹4.87 Cr
Satisfied ₹21.52 Lakh
Company age
41 yrs
Est. 1985
Employees · EPFO
10
Provident fund records
About Finesse Pharmaceuticals Private Limited
Data last updated:
Finesse Pharmaceuticals Private Limited is a private limited company based in Kalol, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 January 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85100GJ1985PTC007568. Its GSTIN is 24AAACF4434E1Z5 (Gujarat).
The company has an authorised share capital of ₹55 Lakh and a paid-up capital of ₹40.91 Lakh. It is led by directors Rajshree Pradeep Kothari and Prasann Bharatkumar Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 827/6 C P Industrial Estate Santej – Rakanpur, Kalol, Gujarat, India – 382721.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.48 Cr. For the same year it recorded a net profit of ₹44.75 Lakh (net margin 3.1%) and EBITDA of ₹1.86 Cr (EBITDA margin 12.9%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 35% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.87 Cr and satisfied charges of ₹21.52 Lakh on record. Court records list 9 cases involving the company, including 4 filed by the company and 5 filed against it.
Finesse Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-09-0008690). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website finessepharmaceutical.com.
Company details
CIN U85100GJ1985PTC007568
Registration Number 007568
Incorporation Date 16 January 1985
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-09-0008690
CIN history
Finesse Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231GJ1985PTC007568. The current CIN is U85100GJ1985PTC007568, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100GJ1985PTC007568 | Current |
| U24231GJ1985PTC007568 | Previous |
Recognitions & Rankings of Finesse Pharmaceuticals
Contact details
Finesse Pharmaceuticals Private Limited's registered office is in Kalol, Gujarat. Its website is finessepharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address827/6 C P Industrial Estate Santej – Rakanpur, Kalol, Gujarat, India – 382721
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Finesse Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Finesse Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Finesse Pharmaceuticals Private Limited
FY 2024 filings availableFinesse Pharmaceuticals Private Limited reported revenue of ₹14.48 Cr for FY 2024.
Revenue · FY 2024
₹14.48 Cr
Net profit · FY 2024
₹44.75 Lakh margin 3.1%
EBITDA · FY 2024
₹1.86 Cr margin 12.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 42%
5 years · compounded
▲ 35%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 43%
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹14.48 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.9% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Finesse Pharmaceuticals Private Limited, buy the company report.
Board of directors of Finesse Pharmaceuticals Private Limited
Finesse Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajshree Pradeep Kothari Also directs: Ahmedabad Bariatrics and Cosmetics Private Limited | Director | 03 Jan 2023 | 3 Years 9 Months | Current |
| Prasann Bharatkumar Shah | Additional Director | 08 Nov 2024 | 1 Years 11 Months | Current |
Auditor
Finesse Pharmaceuticals Private Limited is audited by AJAY VANSJALIA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY VANSJALIA & ASSOCIATES | FY 2024 | 0128842W |
Shareholding
The shareholding of Finesse Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Finesse Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.87 Cr
Satisfied charges
₹21.52 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jul 2025 | 101116338 | Sidbi | ₹2.99 Cr | Open | |
| 21 Apr 2007 | 10050586 | Canara Bank | ₹4.1 Lakh | Open | |
| 11 Feb 2006 | 80029051 | Canara Bank | ₹1.83 Cr | Open | |
| 03 Oct 2011 | 10319553 | Canara Bank | ₹11.52 Lakh | Satisfied | |
| 16 Feb 1998 | 90109749 | Progressive Merantile Co-Op Bank Ltd | ₹10 Lakh | Satisfied |
To see the full charge records of Finesse Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Finesse Pharmaceuticals Private Limited has 9 court cases on record: 4 filed by Finesse Pharmaceuticals, 5 filed against it. All cases are disposed.
Total cases
9
Filed by the company
4
Filed against the company
5
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 4 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal miscellaneous application | Filed against the company by Tata Capital Housing Finance Ltd. | Disposed |
| District court, Ahmedabad, Gujarat | Court case (EXE R) | Filed against the company by Archna Glass Works Private Limited | Disposed |
| High Court, GUJARAT | Court case (COMP) | Filed against the company by Avon Ampoules P.Ltd | Disposed |
| District court, Amreli, Gujarat | Criminal miscellaneous application | Filed by the company against individuals | Disposed |
| District court, Ahmedabad, Gujarat | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of Finesse Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Finesse Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Finesse Pharmaceuticals Private Limited has a workforce of 10 employees on its EPFO records as of Mar 07, 2025, across 1 active EPFO establishment.
Employee count
10
Active EPFO establishments
1
GST
Finesse Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACF4434E1Z5 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Finesse Pharmaceuticals Private Limited, buy the company report.
Recent activity
Finesse Pharmaceuticals Private Limited has 8 board changes on record since 2019: 2 appointments and 6 cessations. The latest: Prasann Bharatkumar Shah was appointed as Additional Director on 08 Nov 2024.
Charges
A charge with Sidbi amounted to Rs. 299.00 Lakh with Charge ID 101116338 was registered on 01 Jul 2025.
Appointed
Prasann Bharatkumar Shah was appointed as Additional Director.
AGM
Finesse Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Pradeep Ravichandra Kothari ceased to be Director.
Ceased
Manthan Pradeep Kothari ceased to be Director.
Filing
Finesse Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Ceased
Rajshree Pradeep Kothari ceased to be Additional Director.
Charges
A charge with Canara Bank of Rs. 183.47 Lakh registered on 11 Feb 2006 with Charge ID 80029051 was modified on 11 Jan 2023.
Appointed
Rajshree Pradeep Kothari was appointed as Director.
Ceased
Rajeshbhai Shyamsundar Shukla ceased to be Managing Director.
Ceased
Harsh Pradeep Kothari ceased to be Additional Director.
Ceased
Shukla Rameshwari Rajeshbhai ceased to be Director.
8 earlier events are in the company report.
Frequently asked questions
Finesse Pharmaceuticals is an active private limited company based in Kalol, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 January 1985 (41+ years old) and is registered under CIN U85100GJ1985PTC007568.
Finesse Pharmaceuticals has 2 current directors:
- Rajshree Pradeep Kothari - Director
- Prasann Bharatkumar Shah - Additional Director
The latest financial statements of Finesse Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Finesse Pharmaceuticals is 24AAACF4434E1Z5, registered in Gujarat.
The CIN (Corporate Identification Number) of Finesse Pharmaceuticals is U85100GJ1985PTC007568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Finesse Pharmaceuticals has 9 court cases on record: 4 filed by the company and 5 filed against it. Most are in the district courts.
Finesse Pharmaceuticals was incorporated on 16 January 1985, making it 41+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Prasann Bharatkumar Shah was appointed as Additional Director on 08 Nov 2024. Pradeep Ravichandra Kothari ceased to be Director on 29 Sep 2024. Manthan Pradeep Kothari ceased to be Director on 18 Jun 2024. Finesse Pharmaceuticals has 8 board changes on record in total.
Yes, Finesse Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-09-0008690).
Finesse Pharmaceuticals can be reached through the website finessepharmaceutical.com. Its registered office is in Kalol, Gujarat, India.